Filtered By:
Source: Heart Rhythm
This page shows you your search results in order of date. This is page number 8.
Order by Relevance | Date
Total 406 results found since Jan 2013.
Po-652-06 a novel measure to identify inequity in the treatment of atrial fibrillation: decreased access to cardioversion/ablation in counties with low health rankings
Adequate treatment of atrial fibrillation (AF) is critical for managing patient stroke risk and quality of life. Cardioversion and ablation (CV/A) procedures are commonly performed to treat AF, yet differences in access to these treatments have not been explored from a population health perspective.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Ashley E. Burch, Jan Wong, William Irish Source Type: research
Po-683-02 4-d intracardiac echocardiography catheter guidance for left atrial appendage occlusion without fluoroscopy
Left atrial (LA) appendage (LAA) occlusion (LAAO) is a valid alternative to anticoagulation for stroke protection in patients with atrial fibrillation. Contrast use elimination is desirable since renal dysfunction is a common comorbidity and could obviate the need for fluoroscopy. Intracardiac echocardiography (ICE) guidance can expedite LAAO procedures.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Thomas Flautt, Akanibo Da-Wariboko, Miguel Valderrabano Source Type: research
Po-649-08 impact of ablation outcome on cognitive function in patients with atrial fibrillation
Emerging evidences suggest increased risk of all forms of dementia in patients with atrial fibrillation (AF) even in the absence of overt stroke.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Sanghamitra Mohanty, Angel Quintero Mayedo, Bryan MacDonald, Carola Gianni, Domenico G. Della Rocca, Faiz Baqai, Mohamed A. Bassiouny, G. Joseph Gallinghouse, J. David Burkhardt, Rodney P. Horton, Rong Bai, Amin Al-Ahmad, Andrea Natale Source Type: research
Po-644-03 impact of pre-procedural planning with a novel cardiac ct software platform on the efficiency of a left atrial appendage closure procedure
Percutaneous left atrial appendage closure (LAAC) is an accepted option for stroke prevention in high-risk patients with atrial fibrillation (AF) unable to take long-term oral anticoagulation. Cardiac CT scans are increasingly being used for pre-procedural planning of structural heart procedures. However, the impact of pre-procedural planning on LAAC procedures is unknown.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Jeromane Tenido-Ng, Stephanie Durkin, Advay G. Bhatt, Elliot Brown, Howard Goldschmidt, Himanshu Gupta, Dan L. Musat, Suneet Mittal Source Type: research
Po-674-04 anticoagulation management and risk of thromboembolism in healthy youth with atrial fibrillation: data from a multi-institutional paces collaborative registry
Stroke is a well-defined complication of atrial fibrillation (AF) in adults. However, the risk of thromboembolism and need for anticoagulation therapy in children and young adults with AF are unknown.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Iqbal El Assaad, Benjamin Hammond, Christopher M. Janson, Elizabeth D. Sherwin, Elizabeth A. Stephenson, Christopher L. Johnsrude, Mary C. Niu, Ira Shetty, David K. Lawrence, Anthony C. McCanta, Seshadri Balaji, Shubhayan Sanatani, Frank A. Fish, Gregory Source Type: research
Po-641-05 safety and in-hospital outcomes of left atrial appendage closure device in patients with heart failure: an analysis from the national inpatient sample database 2015-2018
Left atrial appendage occlusion (LAAO) is a procedure that has been shown to be non-inferior to oral anticoagulation for stroke prevention for patients with atrial fibrillation. There is limited data about the safety of left atrial appendage occlusion (LAAO) in patients with heart failure (HF).
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Carlos Vergara Sanchez, Michael Dangl, Michael Albosta, Ian Ergui, Karla Inestroza, Jennifer Maning, Louis Thomas Vincent, Jelani K. Grant, Bertrand Ebner, Rosario Colombo Source Type: research
Po-671-07 safety of amulet laa occluder and watchman device for left atrial appendage closure in patients with atrial fibrillation
Left atrial appendage (LAA) closure is an alternative to chronic anticoagulation for stroke prevention in patients with nonvalvular atrial fibrillation. Multiple devices were used for LAA closure with Amplatzer Amulet LAA Occluder and Watchman Device being the most used in clinical practice. In August 2021, the FDA approved the use of the Amplatzer Amulet LAA Occluder. There is still a knowledge gap in in the safety profile of the Amplatzer Amulet LAA occluder device in comparison to Watchman device.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Marwan M. Refaat, Abbas Hoteit, Jennifer Jdaidani, Mohamad Bahij Moumneh, Bernard S. Abi-Saleh, Bernard Harbieh, Salim Aramouni, Farah Abdulhai, Maurice Khoury, Fadi Sawaya Source Type: research
Po-670-07 optimising antithrombotic agents in patients undergoing left atrial appendage occlusion
Anticoagulants and/or antiplatelet agents are used in the perioperative period for left atrial appendage occluder (LAAO) implantation to reduce the risk of stroke related to atrial fibrillation (AF) or thrombus from the device. However, the indication for LAAO is often a bleeding condition that may be exacerbated by these drugs.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Balrik Kailey, Michael Koa-Wing, Norman A. Qureshi, Syed M. Sohaib, Christine Shi, Pritpal Padam, James Howard, Prapa Kanagaratnam Source Type: research
Po-670-06 efficacy and safety of left atrial appendage occlusion during cardiac surgery to prevent stroke: a systematic review and meta-analysis
Stroke remains one of the significant causes of morbidity and mortality after cardiac surgery. One stroke occurrence is postoperative atrial fibrillation (pAF), with an incidence ranging between 20% and 40%. PAF predisposes to the formation of atrial thrombus. Most thrombus formations observed in the left atrial appendage (LAA) have triggered significant interest as a potential therapeutic target. Current guidelines recommend the administration of direct oral anticoagulants (DOACs) as the preferred therapy to prevent stroke in patients with atrial fibrillation with a CHA2DS2-VASc of ≥ 2.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Reynald Evan Tugade, Billy Joseph David, Clara Sy Tolentino Source Type: research
Po-670-04 long-term outcomes associated with the highest-risk procedural indications for watchman implantation
There is a scarcity of studies reporting long-term outcomes associated with the range of procedural indications for Watchman implantation in real-world practice, particularly the highest-risk indications of CHA2DS2-VASc ≥5 (very high stroke risk) and intracranial hemorrhage (ICH).
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Usama Daimee, Thomas Boyle, Erica Sheree Hart, Ronald D. Berger Source Type: research
Po-669-06 brain metabolism in patients with atrial fibrillation: insights from a pilot fdg-pet study
Atrial Fibrillation (AF) is an independent risk factor for incident dementia. Overt stroke, microembolism and microbleeds are among the main mechanisms linking this arrhythmia and cognitive dysfunction. Cerebral hypoperfusion related to beat-to-beat blood flow variation during AF can also explain the occurrence of dementia or mild cognitive impairment, as rhythm control strategies were shown to reduce its incidence. However, data regarding brain metabolism patterns in patients with AF are still scarce.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Gabriel Targueta, Vitor Delgado, Marcelo Melo, FRANCISCO CARLOS DA COSTA DARRIEUX Source Type: research
Po-668-02 atrial fibrillation duration by ambulatory electrocardiogram monitor and risk of stroke: insights from the veterans health administration
Reduction in stroke risk associated with oral anticoagulation (OAC) is greatest for implantable device-detected atrial fibrillation (AF) lasting ≥ 24 hours.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Alexander Perino, Jun Fan, Susan Schmitt, Natasha Din, Krishna Pundi, Mintu P. Turakhia Source Type: research
Po-661-07 a photoplethymography-based approach to atrial fibrillation-burden estimation in high-risk patients
Atrial fibrillation (AF) is the most common arrhythmia leading to hospital admission. Its incidence is linked to increased risk of stroke, congestive heart failure, and overall mortality. AF burden is a key determinant of outcomes, but accurate quantification can be limited by the cardiac monitoring period (typically days). Alternatively, longer-term monitoring comes at higher cost and often requires an invasive approach. The introduction of reliable wrist-worn devices may improve access to long-term monitoring of AF burden.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Charles A. Athill, Yuriko Tamura, Steven Szabados, Anthony Battisti, Jeffrey Ellis, Lori Crosson, Judith C. Lenane Source Type: research
Po-661-03 use of a deep learning algorithm to predict paroxysmal atrial fibrillation based on printed electrocardiographic records acquired during sinus rhythm
Atrial fibrillation (AF) is a common type of sustained arrhythmia worldwide. Asymptomatic AF, which occurs frequently, is associated with an increased incidence of ischemic stroke, heart failure, and mortality. A large number of patients with paroxysmal atrial fibrillation (PAF) remain undiagnosed due to the absence of electrocardiographic evidence of AF (AF-ECGs). If PAF could be predicted, targeted screening could improve early detection and treatment of this condition.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Yang Zhou, Yu Chen, Deyun Zhang, Shijia Geng, Guodong Wei, Ying Tian, Shenda Hong, XINGPENG LIU Source Type: research
Po-656-08 insertable cardiac monitor in cryptogenic stroke: left atrial size, atrial ectopic burden, and atrial fibrillation
Insertable cardiac monitor (ICM) is a proven useful tool for the detection of subclinical atrial fibrillation (AF) in patients with embolic stroke of undetermined source (ESUS).
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Ji Hyun Lee, Youngjin Cho, Il-young OH Source Type: research
